https://www.biopharmadive.com/news/peter-marks-fda-sarepta-disagree-rift-elevidys-review/719480/
just doing a bit of reading. Missed the discussion around this recent approval. Good to see actions matching the blah blah blah we value patient voice. Having these ADCOM meetings & other forums videoed & placed on u-tube is good IMO.
banter and General Discussion, page-9943
-
- There are more pages in this discussion • 168 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.090(8.14%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $9.935M | 8.613M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 96840 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 83806 | 11 |
View Market Depth
| Last trade - 14.20pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |